 |
Human monoclonal antibody against phosphorylcholine |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of arteriovenous fistula or arteriovenous graft failure in patients with end stage renal disease receiving hemodialysis or preparing for hemodialysis |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-15 00:00:00 |
| Sponsor | Athera Biotechnologies, AB;117 Sankt Eriksgatan, 4th Floor;Norrmalm |
